Benfluorex, (S)- | 1333167-90-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: Benfluorex, (S)-
• 英文别名: 2-[[(2S)-1-[3-(trifluoromethyl)phenyl]propan-2-yl]amino]ethyl benzoate
• CAS: 1333167-90-0
• 化学式: C₁₉H₂₀F₃NO₂
• 分子量: 351.4
• InChiKey: CJAVTWRYCDNHSM-AWEZNQCLSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  25
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  6

文献信息

• METHOD FOR TREATING EPILEPSY
  申请人：Xenon Pharmaceuticals Inc.

  公开号：US20200030260A1

  公开（公告）日：2020-01-30

  In certain embodiments, the present disclosure is directed to methods and uses for treating a mammal having an epileptic seizure disorder or being at risk for having an epileptic seizure disorder, comprising administering certain herein disclosed isolated fenfluramine enantiomers that are surprisingly effective as anti-epilepsy drugs (AEDs), despite having lower anti-seizure potency than fenfluramine racemate, by virtue of also being less cardiotoxic than fenfluramine racemate. Preferred embodiments contemplate treatment of Dravet syndrome; other preferred embodiments contemplate treatment of other epileptic seizure disorders.

  在某些实施方式中，本公开涉及针对患有癫痫发作障碍或处于患有癫痫发作障碍风险的哺乳动物进行治疗的方法和用途，包括给予某些在此处披露的孤立芬氟拉明对映体，尽管其抗癫痫效力低于芬氟拉明混合物，但由于其心脏毒性也低于芬氟拉明混合物，因此这些对映体出奇地有效作为抗癫痫药物（AEDs）。优选实施方式考虑特拉维特综合征的治疗；其他优选实施方式考虑其他癫痫发作障碍的治疗。
• [EN] METHOD FOR TREATING EPILEPSY<br/>[FR] MÉTHODES DE TRAITEMENT DE L'ÉPILEPSIE
  申请人：XENON PHARMACEUTICALS INC

  公开号：WO2020023923A1

  公开（公告）日：2020-01-30

  In certain embodiments, the present disclosure is directed to methods and uses for treating a mammal having an epileptic seizure disorder or being at risk for having an epileptic seizure disorder, comprising administering certain herein disclosed isolated fenfluramine enantiomers that are surprisingly effective as anti-epilepsy drugs (AEDs), despite having lower anti-seizure potency than fenfluramine racemate, by virtue of also being less cardiotoxic than fenfluramine racemate. Preferred embodiments contemplate treatment of Dravet syndrome; other preferred embodiments contemplate treatment of other epileptic seizure disorders.